Mission
THE ISA ELAINE FOUNDATION IS DEDICATED TO ADVANCING RESEARCH DISCOVERIES ON ULTRA-RARE PEDIATRIC NEURODEGENERATIVE DISEASES, SPECIFICALLY BPAN (BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION) CAUSED BY A MUTATION IN THE WDR45 GENE. BY CHARACTERIZING EARLY-ONSET BPAN IN ISABELLA ELAINE LAZZARA, WE AIM TO UNCOVER INSIGHTS THAT MAY UNLOCK FUTURE TREATMENTS FOR MAJOR NEURODEGENERATIVE DISEASES SUCH AS PARKINSON'S AND ALZHEIMER'S.